Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens-Reference-Cited by-同舟云学术

Design, Synthesis, and Preclinical Characterization of Novel, Highly Selective Indole Estrogens

Published:2001-04-25 Issue:11 Volume:44 Page:1654-1657
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Miller Chris P.¹,Collini Michael D.¹,Tran Bach D.¹,Harris Heather A.¹,Kharode Yogendra P.¹,Marzolf James T.¹,Moran Robert A.¹,Henderson Ruth A.¹,Bender Reinhold H. W.¹,Unwalla Rayomond J.¹,Greenberger Lee M.¹,Yardley John P.¹,Abou-Gharbia Magid A.¹,Lyttle C. Richard¹,Komm Barry S.¹

Affiliation:

1. Wyeth-Ayerst Research, Chemical Sciences, 145 King of Prussia Road, Radnor, Pennsylvania 19087, Wyeth-Ayerst Research Women's Health Research Institute, 145 King of Prussia Road, Radnor, Pennsylvania 19087, Wyeth-Ayerst Research, Biology Chemistry, 145 King of Prussia Road, Radnor, Pennsylvania 19087, and Wyeth-Ayerst Research, Oncology and Immunoinflammatory Research, Pearl River, New York 10965

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm010086m

Reference19 articles.

1. Current perspectives on the benefits of HRT in menopausal women

2. Women’s healthcare in the 21st century

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors;Antioxidants;2023-12-28

2. Effectiveness of Selective Estrogen Receptor Modulators in Breast Cancer Therapy: An Update;Current Medicinal Chemistry;2023-09

3. Design, docking, MD simulation and in-silco ADMET prediction studies of novel indole-based benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy;Pharmacia;2023-05-11

4. Palladium-catalyzed nucleomethylation of alkynes for synthesis of methylated heteroaromatic compounds;Chemical Science;2022

5. Discovery and characterization of potent And‐1 inhibitors for cancer treatment;Clinical and Translational Medicine;2021-12